Associated Papers
Associations between the 1438A/G, 102T/C, and rs7997012G/A polymorphisms of HTR2A and the safety and efficacy of antidepressants in depression: a meta-analysis.
Wan YS et al.
The Pharmacogenomics Journal, 2021
Lack of association between MAOA-uVNTR variants and excessive daytime sleepiness.
Ozen F et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2017
Clinical significance of pharmacogenomic studies in tardive dyskinesia associated with patients with psychiatric disorders.
Chang FC et al.
Pharmacogenomics and Personalized Medicine, 2014
Review and meta-analysis of antidepressant pharmacogenetic findings in major depressive disorder.
Kato M et al.
Molecular Psychiatry, 2010
Pharmacogenetics of selective serotonin reuptake inhibitors and associated adverse drug reactions.
Thomas KL et al.
Pharmacotherapy, 2009
Polymorphisms of the serotonin-2A receptor and catechol-O-methyltransferase genes: a study on fibromyalgia susceptibility.
Tander B et al.
Rheumatology International, 2008
Genetic evaluation of the serotonergic system in chronic fatigue syndrome.
Smith AK et al.
Psychoneuroendocrinology, 2008
The evolutionary significance of cis-regulatory mutations.
Wray GA
Nature Reviews. Genetics, 2007
Family-based association study of serotonergic candidate genes and attention-deficit/hyperactivity disorder in a German sample.
Heiser P et al.
Journal of Neural Transmission (vienna, Austria : 1996), 2007
Molecular genetics of attention-deficit/hyperactivity disorder.
Faraone SV et al.
Biological Psychiatry, 2005
Monoamine oxidase A gene polymorphism, 5-HT 2A receptor gene polymorphism and incidence of nausea induced by fluvoxamine.
Yoshida K et al.
Neuropsychobiology, 2003
Sexually dimorphic relationship of a 5-HT2A promoter polymorphism with obsessive-compulsive disorder.
Enoch MA et al.
Biological Psychiatry, 2001
Select a paper to view details